PRAXIS INVESTMENT MANAGEMENT INC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1056825
GOSHEN, IN
Position in ALNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$894,059
-$88,624 QoQ
Shares Held
2,970
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#413
of 780 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRAXIS INVESTMENT MANAGEMENT INC holds $15,079,585 across 30 Biotechnology names. ALNY ranks #3 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,269 | $2,617,270 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
6,152 | $1,152,146 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,970 | $894,059 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,310 | $816,837 | |
| 5 | INCY |
Incyte Corp
|
6,840 | $775,382 | |
| 6 | MRNA |
Moderna, Inc.
|
10,929 | $765,357 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
15,820 | $559,869 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
2,277 | $548,688 |
All Filings in ALNY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $894,059 | 2,970 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $982,683 | 2,970 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,181,020 | 2,970 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,354,320 | 2,970 | Shares | Sole | 2025-10-01 | |
| 2025-06-30 | $968,487 | 2,970 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $801,959 | 2,970 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $592,981 | 2,520 | Shares | Sole | 2025-01-03 | |
| No filing history on record for this holder in this stock. | ||||||